Cargando…
Public access to protocols of contemporary cancer randomized clinical trials
Access to randomized clinical trial (RCT) protocols is necessary for the interpretation and reproducibility of the study results, but protocol availability has been lacking. We determined the prevalence of protocol availability for all published cancer RCTs in January 2020. We found that only 36.1%...
Autores principales: | Babu, Christopher, Mell, Loren, Lee, Nancy, Zakeri, Kaveh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237482/ https://www.ncbi.nlm.nih.gov/pubmed/34176506 http://dx.doi.org/10.1186/s13063-021-05382-7 |
Ejemplares similares
-
Specificity of Genetic Biomarker Studies in Cancer Research: A Systematic Review
por: Green, Garrett, et al.
Publicado: (2016) -
In Reply to Qureshi et al
por: Hesse, Jennifer, et al.
Publicado: (2022) -
Age of Data at the Time of Publication of Contemporary Clinical Trials
por: Welsh, John, et al.
Publicado: (2018) -
Promoting public access to clinical trial protocols: challenges and recommendations
por: Chan, An-Wen, et al.
Publicado: (2018) -
Radiation Oncology in the 21st Century: Prospective Randomized Trials That Changed Practice… or Didn’t!
por: Zakeri, Kaveh, et al.
Publicado: (2018)